Cigna Group
XMUN:CGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mudanjiang Hengfeng Paper Co Ltd
SSE:600356
|
CN |
|
China Minsheng Banking Corp Ltd
SSE:600016
|
CN |
|
NTC Industries Ltd
BSE:526723
|
IN |
|
AJIS Co Ltd
TSE:4659
|
JP |
|
Medivolve Inc
OTC:MEDVF
|
CA |
|
Tasty PLC
LSE:TAST
|
UK |
|
A
|
Asdion Bhd
KLSE:ASDION
|
MY |
|
Kirby Corp
NYSE:KEX
|
US |
|
Guardforce AI Co Ltd
NASDAQ:GFAI
|
TH |
|
Towa Corp
TSE:6315
|
JP |
|
N
|
Nexgen Energy Ltd
NYSE:NXE
|
CA |
|
C
|
Champ Resto Indonesia Tbk PT
IDX:ENAK
|
ID |
Cigna Group
Other Equity
Cigna Group
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cigna Group
XMUN:CGN
|
Other Equity
-$2.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-8%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Other Equity
-$27m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Other Equity
$200m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Other Equity
-$2.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-8%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other Equity
-$27.6m
|
CAGR 3-Years
62%
|
CAGR 5-Years
30%
|
CAGR 10-Years
21%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cigna Group
Glance View
Cigna Group, a recognized titan in the health services landscape, traces its origins to 1792 when it began as the Insurance Company of North America (INA). This rich history speaks volumes about its deep-rooted expertise and robust resilience in an ever-evolving industry. Today, Cigna operates as a global health services powerhouse, deriving its core revenues from an intricate blend of health insurance products and services targeted towards employers, individuals, and government entities. The company's ability to seamlessly fuse traditional insurance models with innovative health solutions highlights its commitment to improving patient outcomes. Cigna's operational model is anchored on its extensive provider network, supplemented by a suite of digital health tools aimed at enhancing customer engagement. This hybrid approach not only simplifies access to medical care but also reinforces its strategic focus on affordability and personalized health journeys for its clients. Financially, Cigna's success is a byproduct of its diversified revenue streams, encompassing global health care, international markets, and supplemental health benefits. At its core, Cigna makes money through premium collections, investment income, and administrative fees from managing prescription drug plans and health services. With the acquisition of Express Scripts in 2018, Cigna prominently positioned itself in the pharmacy benefits management sector, adding another lucrative revenue channel. This strategic maneuver has fostered vertical integration within the company, aligning its pharmacy services with its insurance offerings to manage costs more effectively. Through a relentless pursuit of operational efficiency and strategic expansion, Cigna continues to leverage its scale and diversified offerings, remaining a key player in delivering accessible and cost-effective health care solutions worldwide.
See Also
What is Cigna Group's Other Equity?
Other Equity
-2.8B
USD
Based on the financial report for Dec 31, 2025, Cigna Group's Other Equity amounts to -2.8B USD.
What is Cigna Group's Other Equity growth rate?
Other Equity CAGR 10Y
-8%
Over the last year, the Other Equity growth was -20%. The average annual Other Equity growth rates for Cigna Group have been -19% over the past three years , -27% over the past five years , and -8% over the past ten years .